MUC6 and tubular adenoma: Here, we assessed GS‐II binding and performed immunostaining for HIK1083 (specific to terminal αGlcNAc residues), MUC5AC, MUC6, and special AT‐rich sequence binding protein 2 (SATB2) in SSLs, MVHPs, and tubular adenomas (TAs).